Dose Finding Trial With a New Treatment (Degarelix) for Prostate Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

189

Participants

Timeline

Start Date

February 29, 2004

Primary Completion Date

June 30, 2005

Study Completion Date

September 30, 2005

Conditions
Prostate Cancer
Interventions
DRUG

degarelix

Degarelix was given as subcutaneous injections.

Trial Locations (39)

Unknown

UCL Saint Luc, Brussels

UZ Gent, Ghent

UZ Gasthuisberg, Leuven

Vivantes Klinikum am Urban, Berlin

Loretto Krankenhaus, Freiburg im Breisgau

Euromed AG Klinik, Fürth

Urologische Universitätsklinikum, Mannheim

Bajcsy-Zsilinszky Hospital, Urology, Budapest

Jahn Ferenc Dél Pesti Hospital, Urology, Budapest

Pez Aladar County Hospital, Győr

BAZ County Hospital, Miskolc

Hospital of Local Gov. Szeged, Urology, Szeged

MÁV Hospital, Urology, Szolnok

AMC, Amsterdam

Atrium MC, Heerlen

Wojewódzki Szpital Specjalisttyczny, Siedlce

Wojewódzki Szpital Specjalisttyczny, Słupsk

CF2 Hospital, Bucharest

Dr. Th Burghele Hospital, Bucharest

Fundeni Hospital, Bucharest

Sf. Ioan Hospital, Bucharest

Botkin Clinical Hospital, Moscow

City Hospital #1, Moscow

City Hospital #29, Moscow

City Hospital #50, Moscow

City Hospital #60, Moscow

Institute of Urology of MoH, Moscow

"Andros Urology Clinic", Saint Petersburg

City Hospital #15, Saint Petersburg

City Hospital #26, Saint Petersburg

Military Medical Academy, Urology, Saint Petersburg

Pavlov Medical School Outpatient, Saint Petersburg

Pavlov medical School, Urology, Saint Petersburg

Sct Petersburg State Medical Academy, Saint Petersburg

370 Clarke Road, Glenwood, Durban

Pretoria Urology Hospital, Hatfield, Pretoria

WITS Medical School, Parktown

401B Medical Centre, Pietermaritzburg

Sunninghill Clinic, Sunninghill

Sponsors
All Listed Sponsors
lead

Ferring Pharmaceuticals

INDUSTRY